Unusual consequences of status epilepticus in Dravet syndrome

被引:48
作者
Chipaux, M. [1 ,2 ,3 ]
Villeneuve, N. [4 ]
Sabouraud, P. [5 ]
Desguerre, I. [1 ]
Boddaert, N. [6 ]
Depienne, C. [7 ]
Chiron, C. [1 ,2 ,3 ]
Dulac, O. [1 ,2 ,3 ]
Nabbout, R. [1 ,2 ,3 ]
机构
[1] Hop Necker Enfants Malad, AP HP, Serv Neuropediat, Ctr Reference Epilepsies Rares, Paris, France
[2] INSERM, U663, F-75015 Paris, France
[3] Univ Paris 05, F-75015 Paris, France
[4] Hop Henri Gastaut, Ctr St Paul, Marseille, France
[5] CHU Reims, Hop Americain, Serv Pediat A, Reims, France
[6] Hop Necker Enfants Malad, AP HP, Serv Radiol Pediat, Paris, France
[7] Hop La Pitie Salpetriere, UF Neurogenet Mol & Cellulaire, Paris, France
来源
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 2010年 / 19卷 / 03期
关键词
Dravet syndrome; Adverse effects of AEDs; Status epilepticus; Barbiturates; Cognitive outcome; SEVERE MYOCLONIC EPILEPSY; INFANCY;
D O I
10.1016/j.seizure.2010.01.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although status epilepticus (SE) affects the course of Dravet syndrome (DS), it rarely alters dramatically psychomotor outcome. We report an unusual pattern in 3 patients who following refractory SE lasting respectively 2, 7 and 12 h experienced persistent and severe cognitive and motor deterioration. We compared these patients to published data and to personal experience in Necker hospital, to find links between severe outcome and clinical features such as treatment or duration of refractory SE. The key point was that anoxoischemic-like lesions appeared on MRI although cardiovascular function had remained stable. Therefore, neither hemodynamic failure, nor abnormalities of cardiac rhythm could explain the lesions and neurological worsening. For theoretical reasons the responsibility of therapy common for the 3 patients, e.g., barbiturates was suspected. (C) 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:190 / 194
页数:5
相关论文
共 16 条
[1]   Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial [J].
Chiron, C ;
Marchand, MC ;
Tran, A ;
Rey, E ;
d'Athis, P ;
Vincent, J ;
Dulac, O ;
Pons, G .
LANCET, 2000, 356 (9242) :1638-1642
[2]  
Coulter D A, 1999, Adv Neurol, V79, P725
[3]   EFFECTS OF THIOPENTAL ON MIDDLE CEREBRAL-ARTERY BLOOD VELOCITIES - A TRANSCRANIAL DOPPLER STUDY IN CHILDREN [J].
DEBRAY, JM ;
GRANRY, JC ;
MONRIGAL, JP ;
LEFTHERIOTIS, G ;
SAUMET, JL .
CHILDS NERVOUS SYSTEM, 1993, 9 (04) :220-223
[4]  
Dravet C, 2002, CURR PROB E, V17, P81
[5]  
Dravet Charlotte, 2005, Adv Neurol, V95, P71
[6]   Status epilepticus: Risk factors and complications [J].
Fountain, NB .
EPILEPSIA, 2000, 41 :S23-S30
[7]   Two cases of sudden unexpected death in epilepsy in a GEFS plus family with an SCN1A mutation [J].
Hindocha, Neeti ;
Nashef, Lina ;
Elmslie, Frances ;
Birch, Rachael ;
Zuberi, Sameer ;
Al-Chalabi, Ammar ;
Crotti, Lia ;
Schwartz, Peter J. ;
Makoff, Andrew .
EPILEPSIA, 2008, 49 (02) :360-365
[8]   Can SCN1A mutations account for SUDEP? Commentary on Hindocha et al [J].
Nabbout, Rima .
EPILEPSIA, 2008, 49 (02) :367-368
[9]   Outcome of convulsive status epilepticus: a review [J].
Novorol, Claire L. ;
Chin, Richard F. M. ;
Scott, Rod C. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (11) :948-951
[10]   Severe myoclonic epilepsy in infants - a review based on the Tokyo Women's Medical University series of 84 cases [J].
Oguni, H ;
Hayashi, K ;
Awaya, Y ;
Fukuyama, Y ;
Osawa, M .
BRAIN & DEVELOPMENT, 2001, 23 (07) :736-748